These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31092221)

  • 1. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
    Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
    BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
    Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
    Saloura V; Cho HS; Kiyotani K; Alachkar H; Zuo Z; Nakakido M; Tsunoda T; Seiwert T; Lingen M; Licht J; Nakamura Y; Hamamoto R
    Mol Cancer Res; 2015 Feb; 13(2):293-304. PubMed ID: 25280969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.
    Wang Y; Chen SY; Karnezis AN; Colborne S; Santos ND; Lang JD; Hendricks WP; Orlando KA; Yap D; Kommoss F; Bally MB; Morin GB; Trent JM; Weissman BE; Huntsman DG
    J Pathol; 2017 Jul; 242(3):371-383. PubMed ID: 28444909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SNHG6 promotes cell proliferation and migration through sponging miR-4465 in ovarian clear cell carcinoma.
    Wu Y; Deng Y; Guo Q; Zhu J; Cao L; Guo X; Xu F; Weng W; Ju X; Wu X
    J Cell Mol Med; 2019 Aug; 23(8):5025-5036. PubMed ID: 31119871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H; Cai Q; Godwin AK; Zhang R
    Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
    Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype.
    Filon M; Gawdzik J; Truong A; Allen G; Huang W; Khemees T; Machhi R; Lewis P; Yang B; Denu J; Jarrard D
    Br J Cancer; 2021 Jul; 125(2):247-254. PubMed ID: 33976366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
    Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Yin Z; Sun Y; Ge S; Sun J
    Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.
    Oki S; Sone K; Oda K; Hamamoto R; Ikemura M; Maeda D; Takeuchi M; Tanikawa M; Mori-Uchino M; Nagasaka K; Miyasaka A; Kashiyama T; Ikeda Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Kawana K; Fukayama M; Osuga Y; Fujii T
    Oncotarget; 2017 Jun; 8(25):40402-40411. PubMed ID: 28418882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
    Bate-Eya LT; Gierman HJ; Ebus ME; Koster J; Caron HN; Versteeg R; Dolman MEM; Molenaar JJ
    Eur J Cancer; 2017 Apr; 75():63-72. PubMed ID: 28214660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.
    Lian R; Ma H; Wu Z; Zhang G; Jiao L; Miao W; Jin Q; Li R; Chen P; Shi H; Yu W
    Mol Cell Biochem; 2018 Feb; 439(1-2):35-43. PubMed ID: 28795320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
    Asangani IA; Ateeq B; Cao Q; Dodson L; Pandhi M; Kunju LP; Mehra R; Lonigro RJ; Siddiqui J; Palanisamy N; Wu YM; Cao X; Kim JH; Zhao M; Qin ZS; Iyer MK; Maher CA; Kumar-Sinha C; Varambally S; Chinnaiyan AM
    Mol Cell; 2013 Jan; 49(1):80-93. PubMed ID: 23159737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]   [Full Text] [Related]  

  • 18. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
    Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
    Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.
    Yu C; Yao X; Zhao L; Wang P; Zhang Q; Zhao C; Yao S; Wei Y
    Neoplasia; 2017 Aug; 19(8):606-616. PubMed ID: 28654864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas.
    Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama N; Otsuki Y; Nakayama S; Miyazaki K
    Br J Cancer; 2012 Jul; 107(2):300-7. PubMed ID: 22653145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.